Alnylam Pharmaceuticals, Inc.
Pharmaceutical company appoints Robert Millman as chief patent counsel
Published in Medicine and Law Weekly, October 15th, 2004
Millman has more than 25 years of experience in the biotechnology sector, and he has served as a consultant for Alnylam since June 2003.
In his position at Alnylam, Millman will be responsible for directing all aspects of the company's intellectual property activities, and will be a member of the company's management team.
"We are delighted to formally welcome Robert to our team," commented Barry Greene, chief operating officer of Alnylam. "He has demonstrated leadership and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- OptoQ AB
Medical technology company signs agreement with Fresenius Medical Care - Albert Einstein College of Medicine
Cryptococcus glucuronoxylomannan IgM have diverse gene use profiles - American Association for Homecare
Fee-for-service rates for oxygen nearly the same as Medicare rates, study shows - Androclus Therapeutics
Biotech firm granted patent for artificial antigen presenting cells - Bristol-Myers Squibb
Settlement awards $11.3 million to U.S. government for Medicaid expenses - Centers for Medicare & Medicaid Services
Low-income beneficiaries have new ways to save with drug discount cards - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
